NEW YORK (GenomeWeb News) – The German Cancer Research Center, or DFKZ, will use Febit’s Geniom RT Analyzer for its research into the roles of microRNAs in cancer, Febit said today.
Heidelberg-based DFKZ will use the Geniom RT analyzer for microarray analysis of miRNA profiles in biological samples.
Febit said the system can be used to fragment and sort large genomes into smaller fractions, which may then be used as samples in mutation analysis and high-throughput sequencing studies.
Febit also said that the analyzer has “a high degree of automation,” it is user-friendly, and it combines hybridization, staining, washing, shaking, and detection into one instrument.
Financial terms of the agreement were not released.